Previous close | 0.1500 |
Open | 1.2000 |
Bid | 0.0000 |
Ask | 4.2000 |
Strike | 380.00 |
Expiry date | 2024-10-18 |
Day's range | 0.1500 - 1.6000 |
Contract range | N/A |
Volume | |
Open interest | 31 |
As the U.S. stock market continues its impressive rally, with the S&P 500 and Dow Jones Industrial Average reaching record highs, investors are increasingly focused on identifying opportunities that may be trading below their estimated fair value. In this buoyant market environment, a good stock is often characterized by strong fundamentals and potential for growth that hasn't yet been fully recognized by the broader market.
Vertex Pharmaceuticals Inc (VRTX) reports robust revenue growth and raises guidance, while addressing acquisition-related losses and strategic hurdles.
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.